| AstraZeneca AG - WAINZUA, Injektionslösung | | 69332 | | 01 | | WAINZUA | | Injektionslösung | | | | | | 14.02.2025 | | |
| | Composition | | Lösung: eplontersenum 56 mg/ml, natrii dihydrogenophosphas dihydricus, dinatrii phosphas, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile, natrium < 1 mmol Natrium (23 mg), 1 ml corresp.. | | Packungsbestandteile | | | | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | PR | PR | B | | No |
|
|
